Literature DB >> 14630721

Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.

Randi Ugleholdt1, Xiaorong Zhu, Carolyn F Deacon, Cathrine Ørskov, Donald F Steiner, Jens J Holst.   

Abstract

The neuroendocrine prohormone convertases 1 and 2 (PC1 and PC2) are expressed in endocrine intestinal L cells and pancreatic A cells, respectively, and colocalize with proglucagon in secretory granules. Mice lacking PC2 have multiple endocrinopathies and cannot process proglucagon to mature glucagon in the pancreas. Disruption of PC1 results in dwarfism and also multiple neuroendocrine peptide processing defects. This study compares the pancreatic and intestinal processing of proglucagon in mice lacking PC1 expression with that in age-matched wild-type controls. Because proglucagon was found to precipitate in acidic extracts, the intestinal processing profile was analyzed in both acidic and neutral extracts by gel filtration, HPLC, and RIA. Supporting a central role for PC2 in glucagon biosynthesis, we found normal processing of proglucagon to glucagon in the pancreas, whereas the intestinal proglucagon processing showed marked defects. Tissue proglucagon levels in null mice were elevated, and proglucagon processing to glicentin, oxyntomodulin, and glucagon-like peptide-1 and -2 (GLP-1 and GLP-2) was markedly decreased, indicating that PC1 is essential for the processing of all the intestinal proglucagon cleavage sites. This includes the monobasic site R(77) and, thereby, production of mature, biologically active GLP-1. We also found elevated glucagon levels, suggesting that factors other than PC1 that are capable of processing to mature glucagon are present in the secretory granules of the L cell. These findings strongly suggest that PC1 is essential for intestinal proglucagon processing in vivo and, thereby, plays an important role in production of the incretin hormone GLP-1 and the intestinotrophic hormone GLP-2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630721     DOI: 10.1210/en.2003-0801

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

Review 1.  T1R and T2R receptors: the modulation of incretin hormones and potential targets for the treatment of type 2 diabetes mellitus.

Authors:  Cedrick D Dotson; Stephan Vigues; Nanette I Steinle; Steven D Munger
Journal:  Curr Opin Investig Drugs       Date:  2010-04

Review 2.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

3.  Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.

Authors:  Sarah Refaie; Sandra Gagnon; Hugo Gagnon; Roxane Desjardins; François D'Anjou; Pedro D'Orléans-Juste; Xiaorong Zhu; Donald F Steiner; Nabil G Seidah; Claude Lazure; Michel Salzet; Robert Day
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

4.  A common variant upstream of the PAX6 gene influences islet function in man.

Authors:  E Ahlqvist; F Turrini; S T Lang; J Taneera; Y Zhou; P Almgren; O Hansson; B Isomaa; T Tuomi; K Eriksson; J G Eriksson; V Lyssenko; L Groop
Journal:  Diabetologia       Date:  2011-09-16       Impact factor: 10.122

5.  Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model.

Authors:  Paola Luciani; Cristiana Deledda; Susanna Benvenuti; Ilaria Cellai; Roberta Squecco; Monica Monici; Francesca Cialdai; Giorgia Luciani; Giovanna Danza; Chiara Di Stefano; Fabio Francini; Alessandro Peri
Journal:  Cell Mol Life Sci       Date:  2010-05-23       Impact factor: 9.261

Review 6.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

7.  Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors.

Authors:  Clare L Kirkpatrick; Piero Marchetti; Francesco Purrello; Salvatore Piro; Marco Bugliani; Domenico Bosco; Eelco J P de Koning; Marten A Engelse; Julie Kerr-Conte; François Pattou; Claes B Wollheim
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

8.  Impaired enteroendocrine development in intestinal-specific Islet1 mouse mutants causes impaired glucose homeostasis.

Authors:  Natalie A Terry; Erik R Walp; Randall A Lee; Klaus H Kaestner; Catherine Lee May
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

9.  Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells.

Authors:  Yoshitaka Hayashi; Michiyo Yamamoto; Hiroyuki Mizoguchi; Chika Watanabe; Ryoichi Ito; Shiori Yamamoto; Xiao-yang Sun; Yoshiharu Murata
Journal:  Mol Endocrinol       Date:  2009-10-09

10.  Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?

Authors:  F K Knop
Journal:  Diabetologia       Date:  2009-09-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.